To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients

Clinical trial NCT04468646 · UNKNOWN

Trial details

NCT number

NCT04468646

Sponsor

Prof. Dr. Fridoon Jawad Ahmad

Status

UNKNOWN

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2020-06-15

Primary completion

2020-07-15

Enrollment

100

View on ClinicalTrials.gov